Secondary Logo

Journal Logo

World Gastroenterology Organisation (WGO) News and Events

Journal of Clinical Gastroenterology: July 2019 - Volume 53 - Issue 6 - p i–ii
doi: 10.1097/MCG.0000000000001232

World Gastroenterology Organisation, Milwaukee, WI

The author declares that there is nothing to disclose.

Address correspondence to: James Melberg, World Gastroenterology Organisation, 555 East Wells Street, Suite 1100, Milwaukee, WI 53202 (e-mail:

World Gastroenterology Organisation (WGO) News and Events



World Congress of Gastroenterology—September 21–24, 2019



Back to Top | Article Outline


  • The World Congress of Gastroenterology is the premier biennial scientific meeting for digestive diseases. In 2019 we are proud to partner with the Turkish Society of Gastroenterology (TSG).
  • Top class scientific program encompassing key areas in Gastroenterology, Hepatology, GI Endoscopy and Surgery delivered by over 100 regional and international leaders in the field.
  • An exceptional Postgraduate Course, featuring hot topics in gastroenterology, liver, microbiota, and advances in GI pharmacology.
  • Four concurrent sessions daily, hands-on workshops, both oral and poster presentations, and exhibitions. Unmatchable platform to showcase your products. Sessions will offer simultaneous translation in Turkish and Russian!
  • Delegates from around the globe. This meeting will provide an opportunity for professionals in the field of gastroenterology, hepatology and related disciplines to come together to learn about the latest research and advancements, collaborate with colleagues and actively participate in this rapidly advancing field.
  • One of WGO’s pillars are Guidelines and Cascades. Featured in the scientific program will be presentations on many of these, including: Celiac Disease, Diet and the Gut, GERD, HCC, Hepatitis B, Hepatitis C, IBD, IBS, NASH and NAFL, and Management of Strongyloidiasis.
  • Presentation of the Master of the WGO, the Henry L. Bockus Medal and Lecture delivered by Prof. Richard Kozarek (USA) as well as the Georges Brohée Medal and Lecture delivered by Prof. Michael Fried (Switzerland). These are among the leading awards in gastroenterology.
  • Istanbul, the only city in the world built on 2 continents, has a strategic setting forming the city’s destiny as an imperial capital for nearly 1600 years, for Roman, Byzantine and Ottoman Empires. This metropolis, proud of its rich history and unequalled natural beauty, offers a friendly welcome and genuine hospitality. Seated on the Bosphorus, some of the most fascinating history will unfold before your eyes, as you visit this magnificent city.
  • Convenience of travel and stay: getting to Istanbul is easy! Well-connected air flight schedules—served by over 50 international airlines at a brand-new international airport in addition to 2 other airports. Whether you are traveling from Latin America, Africa or Asia, the Istanbul International Airport has over 3000 flights per day. Top class hotels at affordable prices within walking distance from the congress venue.
  • Throughout the Congress, attendees will have opportunities to schedule tours and experience the many historic sites in and around Istanbul to learn about its traditions.

Don’t delay, register today! We look forward to seeing you in Istanbul!

Back to Top | Article Outline


The WGO has announced the release of the new Pancreatic Cystic Lesions Guideline. This Guideline is chaired by Prof. Juan Malagelada of the University Hospital Vall D’Hebron in Barcelona, Spain and Dr Nalini Guda of GI Associates in Milwaukee, WI.

Prof. Malagelada states that, “This guideline aims at providing physicians worldwide with a reasonable, up-to-date approach in the management of pancreatic cystic lesions. Since pertinent diagnostic and therapeutic resources are not uniformly available in different areas of the world, these guidelines are meant to be used as appropriate keeping in mind the local resources and patient preferences.”

“Pancreatic cystic lesions” is a conventional term that refers to a well-defined lesion of the pancreas that contains fluid. Most small lesions are detected incidentally when scanning is performed for evaluation of a non–pancreas-related indication or symptoms. The etiology of pancreatic cysts is variable; they may be inflammatory, posttraumatic, or have no known etiology. While most small lesions are benign, some lesions can lead to malignancy and hence the need for further workup, surveillance and management decisions. It is, thus, necessary to obtain a good history and assess the nature of the lesion by appropriate investigations as needed to assess the risk for malignant progression. As potentially malignant lesions cannot be distinguished reliably from benign lesions on clinical and morphologic features alone, further evaluation and/or surveillance may be necessary.

Dr Guda notes that the key points and main practice statements of the Guideline are as follows:

  • Careful patient history and physical evaluation are necessary.
  • At initial cyst fluid aspiration: perform CEA, amylase and cytology.
  • Cysts should be assessed to determine the risk for malignancy or complications.
  • Molecular testing is not routinely done because of limited data and the expense, but it does hold promise for the future.
  • A thorough discussion with the patient regarding the diagnosis, current dilemmas in diagnosis and treatment, economic and emotional burden of investigations should be had before initiation of any surveillance strategy.

The Guideline was created with the global view of many Guideline Review Team members, which in addition to Prof. Malagelada and Dr Guda, include: Khean-Lee Goh (Malaysia), Thilo Hackert (Germany), Peter Layer (Germany), Xavier Molero (Spain), Stephen Pandol (USA), Masao Tanaka (Japan), Muhammed Umar (Pakistan), and Anton LeMair (the Netherlands). The guideline and can be accessed at

With this new Guideline WGO now has a library of 26 Global Guidelines, which are written from a viewpoint of global applicability. Each Guideline goes through a rigorous process of authoring, editing, and peer review, and is as evidence based as possible. WGO is the only organization whose guidelines have adopted a global focus. Each WGO guideline is available in English, French, Mandarin, Portuguese, Russian and Spanish and is updated as new information and evidence is discovered. The Global Guidelines Committee meets each year to discuss updating and creating new guidelines and consists of 30-plus members from around the globe.

Back to Top | Article Outline


The new Diet and the Gut Guideline is now available in Portuguese, Spanish, and Russian translations. They can be found on the WGO website at Given the central role of the digestive tract and its related organs in the processes of digestion and absorption, it should come as no surprise that the food we eat has critical and complex interactions with the gastrointestinal tract and its contents, including the microbiota. The nature of these interactions is influenced not only by the composition of the diet and the integrity of the gastrointestinal tract, but also by psychosocial and cultural factors. The general public—and in particular those who suffer from gastrointestinal ailments—rightly perceive their diet as being a major determinant of such symptoms and seek guidance on optimal dietary regimens. Many medical practitioners, including gastroenterologists, are unfortunately often ill-prepared to deal with such issues. This is a reflection of the lack of education on the topic of diet and nutrition in many curricula.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.